The University of Warwick Library - WebBridge

Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial
Davies, Melanie J..  Diabetes, Obesity and Metabolism.    2019-05-24. .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.